This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
Our Executive Special issues are designed to focus on a theme or a sector trend This allows the magazines advisory board and author community to share their perspectives and insights on key issues impacting and influencing the pharma industry
For the pharmaceutical industry managing supply chain risk has never been a higher priority
Although the vaccines currently approved to prevent the infection caused by the severe acute respiratory syndrome coronavirus SARSCoV known as coronavirus disease COVID and emerging variants have shown to greatly reduce the rates of serious illness and death they appear not fully effective at preventing the infection and disease and long COVID ca...
Pharmacogenomics is the study of the genes their structure function polymorphisms transcription and translation how they interact with each other and with environment
Neglected tropical diseases NTDs affect more than one billion people worldwide Although this group of infectious conditions corresponds to per cent of the global disease burden no innovative drugs have been developed in this field
Menarini AsiaPacific is just over a decade old having established its regional headquarters in Singapore back in November
Neurodegenerative diseases such as Alzheimers disease AD Parkinsons disease PD Huntingtons disease HD and Amyotrophic lateral sclerosis ALS are a group of agerelated progressive disorders initiated by the neuronal loss that eventually leads to cognitive and movement disorders
The SARSCoV pandemic has required new methods for rapidly developing effective vaccines and drugs to treat COVID patients
Fungi are ubiquitous in nature and cause disease in humans animals and especially plants
An obstacle in the development of new therapies is often the poor solubility of many drugs in the research pipelineAn obstacle in the development of new therapies is often the poor solubility of many drugs in the research pipeline Almost per cent of them have a little or no water solubility The term poor solubility applies when the maximum concent...
More than one billion people are impacted by chronic and acute lung diseases globally Infact noncommunicable diseases such as chronic respiratory diseases are among the biggest reasons for fatality WHO
Clinical trials are an integral part of drug development that decide the outcome of the newly developed or the newly formulated medicines
Patients with PHTN may present with multiple systemic involvement and symptoms masking the underlying problem
The importance of jointly analysing the manufacturing facilitys maturity and performance was outlined in the article The Link between Plant Performance Maturity Seeing the whole picture
The pharmaceutical industry is one where decades of innovation lead to one new product like a drug or vaccine
Nearly million people worldwide are affected by asthma which left untreated or uncontrolled decreases quality of life and increases the risk of developing chronic obstructive pulmonary disease COPD
As is the case in most scientific disciplines the most common way to determine how something works is to break it down identify and quantify its component parts and then see how they work together to function as a whole
Emerging technologies can help you automate processes in ways believed impossible just five years ago
